Brown E, Harrison R, Havrylyuk D, McBride S, Glazer E, Castellano F
Chem Commun (Camb). 2025; .
PMID: 40008896
PMC: 11863996.
DOI: 10.1039/d4cc06807f.
DeWitt C, Heidbreder A, Hancock G, Bhattacherjee A
J Phys Chem A. 2025; 129(9):2265-2274.
PMID: 39993167
PMC: 11891904.
DOI: 10.1021/acs.jpca.5c00367.
Cole H, Vali A, Roque 3rd J, Shi G, Talgatov A, Kaur G
Inorg Chem. 2024; 63(21):9735-9752.
PMID: 38728376
PMC: 11166183.
DOI: 10.1021/acs.inorgchem.3c04382.
Havrylyuk D, Heidary D, Glazer E
Biomolecules. 2024; 14(4).
PMID: 38672458
PMC: 11048704.
DOI: 10.3390/biom14040441.
Sasaki H, Nakagawa I, Furuta T, Yokoyama S, Morisaki Y, Saito Y
Cell Mol Neurobiol. 2024; 44(1):32.
PMID: 38568450
PMC: 10991049.
DOI: 10.1007/s10571-024-01464-7.
Photoactivatable Ruthenium Complexes Containing Minimal Straining Benzothiazolyl-1,2,3-triazole Chelators for Cancer Treatment.
Ballester F, Hernandez-Garcia A, Santana M, Bautista D, Ashoo P, Ortega-Forte E
Inorg Chem. 2024; 63(14):6202-6216.
PMID: 38385171
PMC: 11005040.
DOI: 10.1021/acs.inorgchem.3c04432.
A Ru(II)-Strained Complex with 2,9-Diphenyl-1,10-phenanthroline Ligand Induces Selective Photoactivatable Chemotherapeutic Activity on Human Alveolar Carcinoma Cells via Apoptosis.
Mansour N, Mehanna S, Bodman-Smith K, Daher C, Khnayzer R
Pharmaceuticals (Basel). 2024; 17(1).
PMID: 38256884
PMC: 10819265.
DOI: 10.3390/ph17010050.
Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents.
Cole H, Vali A, Roque 3rd J, Shi G, Kaur G, Hodges R
Inorg Chem. 2023; 62(51):21181-21200.
PMID: 38079387
PMC: 10754219.
DOI: 10.1021/acs.inorgchem.3c03216.
Ruthenium-Based Photoactivated Chemotherapy.
Bonnet S
J Am Chem Soc. 2023; 145(43):23397-23415.
PMID: 37846939
PMC: 10623564.
DOI: 10.1021/jacs.3c01135.
Binding of Stimuli-Responsive Ruthenium Aqua Complexes with 9-Ethylguanine.
Maeda A, Tokumoto J, Kojima S, Fujimori K, Moriuchi-Kawakami T, Hirahara M
ACS Omega. 2023; 8(40):37391-37401.
PMID: 37841177
PMC: 10569010.
DOI: 10.1021/acsomega.3c05343.
Tricolor visible wavelength-selective photodegradable hydrogel biomaterials.
Rapp T, DeForest C
Nat Commun. 2023; 14(1):5250.
PMID: 37640707
PMC: 10462736.
DOI: 10.1038/s41467-023-40805-w.
Ligand Rigidity Steers the Selectivity and Efficiency of the Photosubstitution Reaction of Strained Ruthenium Polypyridyl Complexes.
Hakkennes M, Meijer M, Menzel J, Goetz A, Van Duijn R, Siegler M
J Am Chem Soc. 2023; 145(24):13420-13434.
PMID: 37294954
PMC: 10299800.
DOI: 10.1021/jacs.3c03543.
Steric hindrance, ligand ejection and associated photocytotoxic properties of ruthenium(II) polypyridyl complexes.
Herrera-Ramirez P, Berger S, Josa D, Aguila D, Caballero A, Fontova P
J Biol Inorg Chem. 2023; 28(4):403-420.
PMID: 37059909
PMC: 10149480.
DOI: 10.1007/s00775-023-01998-z.
Photo-induced telomeric DNA damage in human cancer cells.
Weynand J, Episkopou H, Le Berre G, Gillard M, Dejeu J, Decottignies A
RSC Chem Biol. 2022; 3(12):1375-1379.
PMID: 36544575
PMC: 9709782.
DOI: 10.1039/d2cb00192f.
Photosubstitution in a trisheteroleptic ruthenium complex inhibits conjunctival melanoma growth in a zebrafish orthotopic xenograft model.
Chen Q, Cuello-Garibo J, Bretin L, Zhang L, Ramu V, Aydar Y
Chem Sci. 2022; 13(23):6899-6919.
PMID: 35774173
PMC: 9200134.
DOI: 10.1039/d2sc01646j.
Ru(II) photocages enable precise control over enzyme activity with red light.
Havrylyuk D, Hachey A, Fenton A, Heidary D, Glazer E
Nat Commun. 2022; 13(1):3636.
PMID: 35752630
PMC: 9233675.
DOI: 10.1038/s41467-022-31269-5.
Enhanced cellular uptake and photochemotherapeutic potential of a lipophilic strained Ru(ii) polypyridyl complex.
Mehanna S, Mansour N, Audi H, Bodman-Smith K, Mroueh M, Taleb R
RSC Adv. 2022; 9(30):17254-17265.
PMID: 35519840
PMC: 9064604.
DOI: 10.1039/c9ra02615k.
Factors that influence singlet oxygen formation vs. ligand substitution for light-activated ruthenium anticancer compounds.
Papish E, Oladipupo O
Curr Opin Chem Biol. 2022; 68:102143.
PMID: 35483128
PMC: 9133143.
DOI: 10.1016/j.cbpa.2022.102143.
Photocytotoxicity and photoinduced phosphine ligand exchange in a Ru(ii) polypyridyl complex.
Steinke S, Gupta S, Piechota E, Moore C, Kodanko J, Turro C
Chem Sci. 2022; 13(7):1933-1945.
PMID: 35308843
PMC: 8848995.
DOI: 10.1039/d1sc05647f.
Anticancer Agent with Inexplicable Potency in Extreme Hypoxia: Characterizing a Light-Triggered Ruthenium Ubertoxin.
Cole H, Roque 3rd J, Shi G, Lifshits L, Ramasamy E, Barrett P
J Am Chem Soc. 2021; 144(22):9543-9547.
PMID: 34882381
PMC: 9177514.
DOI: 10.1021/jacs.1c09010.